Telepractice Supported Delivery of LSVT®LOUD This article outlines the essential features and underlying principles of Lee Silverman Voice Treatment (LSVT®LOUD) and explores the delivery of this treatment via telepractice. A detailed summary of the core features of LSVT®LOUD and the principles underpinning this treatment are presented. Current evidence to support the feasibility and validity of ... Article
Article  |   October 01, 2011
Telepractice Supported Delivery of LSVT®LOUD
Author Affiliations & Notes
  • Deborah Theodoros
    School of Health and Rehabilitation Sciences, The University of QueenslandSt. Lucia, Australia
  • Lorraine Ramig
    National Center for Voice and Speech, University of Colorado-Boulder, Boulder, CO
  • Lorraine Ramig receives lecture honoraria and has ownership interest in LSVT® Global, Inc.
    Lorraine Ramig receives lecture honoraria and has ownership interest in LSVT® Global, Inc.×
  • Deborah Theodoros is associate professor and head of the Division of Speech Pathology within the School of Health and Rehabilitation Sciences at the University of Queensland. Her research has focused on the assessment and treatment of motor speech disorders associated with progressive and nonprogressive neurological disorders. Theodoros is a founder and codirector of a multidisciplinary telerehabilitation research unit at the University of Queensland, which is involved in the development and validation of telerehabilitation applications for the assessment and treatment of neurogenic communication disorder, as well as physiotherapy and occupational therapy applications.
    Deborah Theodoros is associate professor and head of the Division of Speech Pathology within the School of Health and Rehabilitation Sciences at the University of Queensland. Her research has focused on the assessment and treatment of motor speech disorders associated with progressive and nonprogressive neurological disorders. Theodoros is a founder and codirector of a multidisciplinary telerehabilitation research unit at the University of Queensland, which is involved in the development and validation of telerehabilitation applications for the assessment and treatment of neurogenic communication disorder, as well as physiotherapy and occupational therapy applications.×
  • Lorraine Ramig is a professor in the Department of Speech-Language and Hearing Sciences (SLHS) at the University of Colorado-Boulder, a senior scientist at the National Center for Voice and Speech (NCVS), an adjunct professor at Columbia Teacher's College in New York City, and founder/president of the LSVT® Foundation (a non-profit organization). She is a fellow of the American Speech-Language-Hearing Association and has received the Honors of the Association. Ramig and her colleagues developed the LSVT® treatment for patients with Parkinson disease. Her research is funded by the National Institutes of Health.
    Lorraine Ramig is a professor in the Department of Speech-Language and Hearing Sciences (SLHS) at the University of Colorado-Boulder, a senior scientist at the National Center for Voice and Speech (NCVS), an adjunct professor at Columbia Teacher's College in New York City, and founder/president of the LSVT® Foundation (a non-profit organization). She is a fellow of the American Speech-Language-Hearing Association and has received the Honors of the Association. Ramig and her colleagues developed the LSVT® treatment for patients with Parkinson disease. Her research is funded by the National Institutes of Health.×
Article Information
Speech, Voice & Prosodic Disorders / Voice Disorders / Special Populations / Older Adults & Aging / Telepractice & Computer-Based Approaches / Speech, Voice & Prosody / Articles
Article   |   October 01, 2011
Telepractice Supported Delivery of LSVT®LOUD
SIG 2 Perspectives on Neurophysiology and Neurogenic Speech and Language Disorders, October 2011, Vol. 21, 107-119. doi:10.1044/nnsld21.3.107
SIG 2 Perspectives on Neurophysiology and Neurogenic Speech and Language Disorders, October 2011, Vol. 21, 107-119. doi:10.1044/nnsld21.3.107

This article outlines the essential features and underlying principles of Lee Silverman Voice Treatment (LSVT®LOUD) and explores the delivery of this treatment via telepractice. A detailed summary of the core features of LSVT®LOUD and the principles underpinning this treatment are presented. Current evidence to support the feasibility and validity of synchronous and asynchronous delivery of LSVT®LOUD to people with Parkinson disease (PD) is reviewed. Technology specifications, cost-benefit analyses, and patient satisfaction are discussed. The challenges involved in delivery of LSVT®LOUD via telepractice, such as inconsistent audio and video quality during videoconferencing, accurate measurement of vocal parameters, technical skill level of the clinician, and patient candidacy, are highlighted. LSVT®LOUD can be effectively and reliably delivered via telepractice. Improvements in telecommunications are required to overcome some of the technology challenges encountered in this mode of delivery. Positive benefits of online treatment in relation to savings in time and money and reduced carer burden are emerging. Patient satisfaction with telepractice in the management of the speech disorder associated with PD is high. The uptake of LSVT®LOUD into telepractice is likely to steadily increase with advances in mobile technologies and web-based applications designed to deliver this treatment.

Become a SIG Affiliate
Pay Per View
Entire SIG 2 Perspectives on Neurophysiology and Neurogenic Speech and Language Disorders content & archive
24-hour access
This Issue
24-hour access
This Article
24-hour access
We've Changed Our Publication Model...
The 19 individual SIG Perspectives publications have been relaunched as the new, all-in-one Perspectives of the ASHA Special Interest Groups.